Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"7,301 (5,710, 8,428)","44.4% (37.6%, 49.6%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","44.4% (37.6%, 49.6%)","11.1 (9.4, 12.4)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","11.1 (9.4, 12.4)",,,,,
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.500)","7,521 (5,849, 8,748)","53.4% (42.1%, 59.6%)","15.7% (11.4%, 20.1%)","1.6% (1.0%, 2.2%)","36.1% (28.9%, 40.4%)","13.3 (10.5, 14.9)","3.9 (2.9, 5.0)","0.4 (0.2, 0.5)","9.0 (7.2, 10.1)","3.0% (1.2%, 5.3%)","20.2% (8.2%, 33.7%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-18.6% (-27.3%, -6.0%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.750)","7,664 (6,027, 8,876)","54.4% (44.1%, 62.9%)","24.0% (16.4%, 30.1%)","2.4% (1.5%, 3.3%)","28.1% (21.4%, 32.8%)","13.6 (11.0, 15.7)","6.0 (4.1, 7.5)","0.6 (0.4, 0.8)","7.0 (5.3, 8.2)","5.0% (2.0%, 7.2%)","22.6% (10.2%, 41.6%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-36.5% (-50.0%, -22.1%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=1.000)","7,806 (6,105, 9,104)","54.6% (42.2%, 65.0%)","31.8% (22.5%, 41.8%)","3.1% (1.9%, 4.5%)","19.7% (11.8%, 26.6%)","13.6 (10.5, 16.2)","7.9 (5.6, 10.4)","0.8 (0.5, 1.1)","4.9 (3.0, 6.6)","6.9% (4.5%, 9.5%)","22.9% (11.1%, 36.9%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-55.3% (-73.9%, -36.8%)"
